Answers are grounded in this paper and cite their sources.
Among men receiving androgen-deprivation therapy for prostate cancer, there is a high frequency of the metabolic syndrome and an increased risk of cardiovascular death. How the loss of anabolic signals leads to sarcopenia and metabolic abnormalities may be informative.
No takes yet. Share an insight, caveat, or question.
Basaria et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: